NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Aug. 26, 2021 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that...
Aurora Spine Corporation Announces First Patients in Multicenter Study of ZIP® Interspinous Fixation Device
CARLSBAD, Calif., Aug. 10, 2021 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that the first patients have been...
Aurora Spine Corporation Announces FDA 510(k) Clearance for DEXA-C™ Cervical Interbody System
Product approval is the first in the world using Company's proprietary and patented DEXA Technology™ for custom made implants based upon matching patient's bone densityCARLSBAD, Calif., Aug. 03, 2021 -- Aurora Spine Corporation ("Aurora Spine" or the "Company")...
Aurora Spine Corporation to Participate in Alliance Global Partners Virtual MedTech Summer Conference
CARLSBAD, Calif., July 28, 2021 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced its management team will be...
Aurora Spine Corporation to Attend Third Annual American Society of Pain & Neuroscience Conference
- As part of conference, Aurora to host a hands-on Training Lab - CARLSBAD, Calif., July 21, 2021 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal...
Aurora Spine Corporation to Present at the Lytham Partners Summer 2021 Investor Conference
CARLSBAD, Calif., June 08, 2021 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will participate in the...
Aurora Spine Corporation Reports First Quarter 2021 Financial Results
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICE Continued improvement in gross margin to 49% in the first quarter 2021 validates the Company's current strategy of introducing more proprietary products and the addition of the Pain division....
Aurora Spine receives IRB approval to commence registration for Multicenter Study of its SiLO™ Device for SI Joint Pain
CARLSBAD, Calif., May 06, 2021 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it has received Institutional...
Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2020 Financial Results
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., April 30, 2021 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that...
Aurora Spine receives IRB approval for Multicenter Study of its ZIP® Interspinous Fixation Device for Relief of Back Pain
CARLSBAD, Calif., March 29, 2021 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it has received...